Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Cevimeline (trade name Evoxac) is a synthetic analog of the natural alkaloid muscarine with a particular agonistic effect on M1 and M3 receptors. It is used in the treatment of dry mouth and Sjögren's disease.
Art, Side effects & Mechanism of action
Explore the main themes, entities and connections around Cevimeline. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
mouth m1 dry evoxac effect m3 receptors trade name particular used treatment sjögren's capsules side effects xerostomia muscarine include synthetic
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Cevimeline | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Cevimeline | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Cevimeline | ATC code | N07AX03 (WHO) | 1.00 | infobox |
| Cevimeline | CAS Number | 107233-08-9 Y | 1.00 | infobox |
| Cevimeline | ChEBI | CHEBI:3568 N | 1.00 | infobox |
| Cevimeline | ChEMBL | ChEMBL1201267 N | 1.00 | infobox |
| Cevimeline | ChemSpider | 75707 Y | 1.00 | infobox |
| Cevimeline | CompTox Dashboard (EPA) | DTXSID801342027 DTXSID40274384, DTXSID801342027 | 1.00 | infobox |
| Cevimeline | DrugBank | DB00185 Y | 1.00 | infobox |
| Cevimeline | Formula | C10H17NOS | 1.00 | infobox |
| Cevimeline | KEGG | D07667 Y | 1.00 | infobox |
| Cevimeline | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Cevimeline | MedlinePlus | a608025 | 1.00 | infobox |
| Cevimeline | Molar mass | 199.31 g·mol−1 | 1.00 | infobox |
| Cevimeline | Pregnancy category | C | 1.00 | infobox |
| Cevimeline | Protein binding | <20% | 1.00 | infobox |
| Cevimeline | PubChem CID | 83898 | 1.00 | infobox |
| Cevimeline | Routes of administration | By mouth (capsules) | 1.00 | infobox |
| Cevimeline | Trade names | Evoxac | 1.00 | infobox |
| Cevimeline | UNII | K9V0CDQ56E | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.